- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
B-cell lymphoma and T-cell lymphoma are two types of non-Hodgkin lymphoma. Lymphoma is a type of cancer that starts in lymphocytes, that are cells of the immune system. Within the patients with non-Hodgkin’s lymphoma, about 85 percent have B-cell lymphoma.
Showing all 2 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD20 , CD3 |
Bispecific Antibody |
Columvi® |
1 mg/mL |
– |
0,1 mg |
tba |
tba |
390,00 € |
||
CD79b |
Antibody-drug conjugate (ADC) |
Polivy® |
20 mg/mL |
– |
1 mg |
-80 °C |
06/2024 |
536,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin